FANALEX
ActiveSummary
The computed 12-month bankruptcy probability of FANALEX is 1.7% (moderate). The 2025 annual accounts show equity of €60,083 and a net result of €205,219. Equity is growing by about 9.6% per year across the filed financial years. Its solvency ranks better than 44% of 4,606 sector peers (NACE 56, financial year 2025). The company has been active since 2001 and the Belgian Official Gazette contains no insolvency or warning signals.
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
30-07
NBB filing
Annual accounts filed
financial year 2025 · abbreviated format
2025
30-09
NBB filing
Annual accounts filed
financial year 2024 · micro format · 61 days late
2024
31-12
Financial
Highest result from 2018 to 2025net €257,794 ▲293%
Operating result €257,948, net result €257,794, both a record.
31-08
NBB filing
Annual accounts filed
financial year 2023 · micro format · 31 days late
16-04
NBB filing
Annual accounts filed
financial year 2022 · micro format · 260 days late
2022
31-12
Financial
Back to profitnet €6,848
Net result €6,848 after 4 loss-making years.
31-12
Financial
Liquidity more than 34 timescurrent ratio 1.02
Current ratio from 0.03 to 1.02.
10-11
NBB filing
Annual accounts filed
financial year 2021 · micro format · 102 days late
2021
27-08
NBB filing
Annual accounts filed
financial year 2020 · micro format · 27 days late
2020
31-08
NBB filing
Annual accounts filed
financial year 2019 · micro format · 31 days late
2019
31-08
NBB filing
Annual accounts filed
financial year 2018 · micro format · 31 days late
2018
31-07
NBB filing
Annual accounts filed
financial year 2017 · micro format
2017
29-09
NBB filing
Annual accounts filed
financial year 2016 · micro format · 60 days late
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 22 annual accounts filed, the latest 10 are here; all 22 are under Financials.
0 of 4 deeds read
About the unread acts
We know of 4 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.